In-vitro activity of nisin against clinical isolates of Clostridium difficile.

Bartoloni, A; Mantella, A; Goldstein, B P; Dei, R; Benedetti, M; Sbaragli, S; Paradisi, F

Bartoloni, A; Mantella, A; Goldstein, B P; Dei, R; Benedetti, M; Sbaragli, S; Paradisi, F.

Affiliation

Bartoloni A; Clinica Malattie Infettive, Università di Firenze, Ospedale di Careggi, Viale Morgagni 85, I-50134 Florence, Italy. bartolonia@ao-careggi.toscana.it

J Chemother ; 16(2): 119-21, 2004 Apr.

Article in En | MEDLINE | ID: mdl-15216943

Subject(s)

Anti-Bacterial Agents/pharmacology; Clostridioides difficile/drug effects; Nisin/pharmacology; Anti-Bacterial Agents/therapeutic use; Cross Infection/prevention & control; Enterocolitis, Pseudomembranous/prevention & control; Humans; Metronidazole/pharmacology; Microbial Sensitivity Tests; Nisin/therapeutic use; Vancomycin/pharmacology

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Clostridioides difficile / Anti-Bacterial Agents / Nisin Limits: Humans Language: En Journal: J Chemother Journal subject: ANTINEOPLASICOS / TERAPIA POR MEDICAMENTOS Year: 2004 Type: Article Affiliation country: Italy

Search on Google

XML

PubMed Links